IBM’s Credibility Gap Widens as Mainframe Rout Puts Software Promise to the Test

IBM shares teeter near a 52-week low after Q2 earnings reveal a 42% mainframe sales collapse, despite 5% software growth. Guidance cut and oversold RSI signal uncertainty.

IBM is caught in a tug-of-war between its resilient software business and a hardware collapse so severe it has dragged the stock to within a hair’s breadth of its 52-week low. Shares closed at €179.98, just 0.82% above the trough of €178.52, after losing 6.06% in a single week. The trigger was a second-quarter earnings report that laid bare a widening chasm between the company’s growth engines.

Revenue for the period came in at $17.2 billion, a meager 1% year-over-year increase that masks a dramatic divergence beneath the surface. The software segment, now accounting for roughly 45% of total revenue, grew 5% to $7.8 billion. But the infrastructure division cratered 7% to $3.8 billion, dragged down by a 42% plunge in mainframe sales from the IBM Z unit — a collapse the management attributes to the late-cycle phase of the current hardware refresh.

The immediate fallout has been a crisis of confidence. IBM’s relative strength index has sunk to 29.1, deep in oversold territory, and the stock is trading roughly 22% below its 50-day moving average. The 30-day annualized volatility sits at nearly 84%, reflecting a market that has yet to settle on a narrative.

A Forecast That Rings Hollow

What has unnerved investors most is not just the magnitude of the mainframe decline, but the manner in which the company’s guidance unraveled. As recently as January, management signaled full-year revenue growth above 5%. That projection was reaffirmed in April. Now, IBM has slashed its outlook to a range of 4% to 5% — a downward revision that, while modest in percentage terms, represents a significant breach of trust.

The infrastructure business was supposed to see only a low single-digit decline following the launch of the z17 system. Instead, the actual drop was multiples of that forecast. The question hanging over the stock is whether this is a cyclical pause — a normal digestion period after a product cycle peak — or a structural shift as enterprise customers permanently redirect IT budgets toward AI infrastructure at the expense of IBM’s legacy hardware.

The Bull Case: Recurring Revenue as a Shock Absorber

Optimists point to the machinery beneath the noise. Software now contributes nearly 44% of IBM’s total revenue, and within that segment, subscription and consumption-based models — which make up 80% of the portfolio — grew 8%. Annual recurring revenue reached $24.6 billion. Red Hat accelerated to 11% growth, HashiCorp posted a record quarter for new bookings, and Confluent, in its first full quarter under IBM ownership, is said to be tracking “on plan.”

Crucially, management left its free cash flow guidance untouched. IBM continues to expect an additional $1 billion in free cash flow for the current year. With the stock trading 24% below its 200-day moving average and an RSI signaling deeply oversold conditions, technical analysts see the potential for a bounce. The current analyst consensus price target of €239.87 implies upside of nearly 35% — though that figure was set before the guidance cut and is likely to be revised downward.

The Bear Case: Structural Erosion and a Credibility Problem

Skeptics argue the mainframe collapse is a symptom of something more pernicious: a broad reallocation of enterprise capital toward AI infrastructure, often at the expense of IBM’s traditional product lines. This pattern is not unique to IBM — other technology companies are feeling the same budget shift — but the speed and severity of the decline have caught management off guard.

The consulting business, at $5.3 billion in revenue, is stagnating. That flatlining could signal that clients are prioritizing hardware and storage investments — frequently with rival vendors — over the digital transformation projects that feed IBM’s services arm. If that trend persists, the stock’s 12-month decline of nearly 25% could deepen.

Then there is the credibility issue. Having underestimated the customer exodus once, investors are left wondering whether the new 4% to 5% growth floor will hold, or whether further downgrades are coming if the AI-driven budget shift proves to be a multi-quarter trend rather than a one-off adjustment.

What Comes Next

For the immediate term, the technical picture offers some hope. As long as the stock holds above the €178.52 support level, a relief rally from oversold conditions remains the most probable scenario. The next milestone would be the 50-day moving average at €228.76.

But a sustainable turnaround requires delivery. The raised full-year forecast of 4% to 5% growth and the promised $1 billion free cash flow improvement must remain achievable despite the hardware weakness. The next concrete test will come with third-quarter results in October, which will show whether the deferred orders management cited have actually closed, and whether the software business can continue to compensate for the infrastructure drag.

In the meantime, income-focused investors have a date to watch: the board declared a quarterly dividend of $1.69 per share, payable on September 10, 2026, to shareholders of record on August 10, 2026. That payout, along with the October earnings report, will determine whether IBM’s current valuation represents a buying opportunity — or a value trap.